Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Identifying Suspicious Skin Lesions with a Noninvasive, Painless Device

Published: Monday, October 28, 2013
Last Updated: Sunday, October 27, 2013
Bookmark and Share
VivaScope®cellular imaging devices from Caliber Imaging & Diagnostics.

One in five Americans will develop skin cancer. According to a 2007 study in Archives of Dermatology, more than 3.5 million skin cancers are diagnosed annually-more new cases than breast, prostate, lung and colon cancers combined.

One might think that most people wouldn't hesitate to consult a dermatologist or their general practitioner about any bump, mole or discoloration on their body, since many skin cancers can now be successfully treated if found sufficiently early.

It is surprising that anyone with a skin lesion would hesitate before seeking medical evaluation - one excuse people give is that if they ignore it, it will just go away. Why else do people wait? Some may honestly believe their moles are nothing to worry about.

Others are terrified that a biopsy would leave a scar, a concern that does hold some validity since the majority of skin lesions are benign, but until recently, could only be proven benign by performing a biopsy and examining the surgically removed tissue under a microscope.

One innovative company, Caliber Imaging & Diagnostics, led by CEO L. Michael Hone, has taken the steam out of that last excuse with their FDA-cleared VivaScope®cellular imaging devices.

These new tools allow physicians to biopsy and technicians to evaluate a patient's skin, at and below the skin surface, using imaging rather than surgical options.

Says Hone: "The best medicine with regard to skin cancer is prevention. One should always consider sun protection, apply SPF-30 every day and wear a hat and sunglasses outdoors. The second-best medicine is to consult one's health care provider immediately when one spots anything that might be the least bit questionable. And when a doctor is consulted, ask if they have a noninvasive way to biopsy skin. Doctors should want to provide patients with a painless, noninvasive optical skin biopsy in lieu of the traditional biopsy to help them make a diagnosis."

The company is already marketing its VivaScope systems, including two handheld VivaScopes, the 1500 and 3000, and the VivaScope 2500 for use in the operating room. Another advantage: no waiting. Obtaining the image takes only five to 10 minutes.

"Our technology can image down into the entire lesion, layer by layer, and immediately help doctors eliminate or diagnose a variety of skin diseases and disorders," says Hone.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos